|
US5322691A
(en)
*
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
|
US5989579A
(en)
*
|
1986-10-02 |
1999-11-23 |
Escalon Medical Corp. |
Ocular insert with anchoring protrusions
|
|
KR0185215B1
(ko)
*
|
1990-11-30 |
1999-05-01 |
요시다 쇼오지 |
서방성 안구삽입용 약제
|
|
WO1994008538A1
(fr)
*
|
1992-10-22 |
1994-04-28 |
Aktsionernoe Obschestvo 'olvik' |
Membrane oculaire medicinale et son procede de production
|
|
ES2150487T3
(es)
*
|
1993-02-26 |
2000-12-01 |
Santen Pharmaceutical Co Ltd |
Tapon escleral biodegradable.
|
|
AU731486B2
(en)
*
|
1993-11-15 |
2001-03-29 |
Allergan, Inc. |
Biocompatible ocular implants
|
|
US5443505A
(en)
*
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5773021A
(en)
*
|
1994-03-14 |
1998-06-30 |
Vetoquinol S.A. |
Bioadhesive ophthalmic insert
|
|
US5466233A
(en)
*
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
|
US6063396A
(en)
*
|
1994-10-26 |
2000-05-16 |
Houston Biotechnology Incorporated |
Methods and compositions for the modulation of cell proliferation and wound healing
|
|
US6063116A
(en)
*
|
1994-10-26 |
2000-05-16 |
Medarex, Inc. |
Modulation of cell proliferation and wound healing
|
|
US5516808A
(en)
*
|
1994-10-27 |
1996-05-14 |
Sawaya; Assad S. |
Topical cellulose pharmaceutical formulation
|
|
US6369116B1
(en)
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
WO1997002019A1
(en)
*
|
1995-06-30 |
1997-01-23 |
Baylor University |
Polyester/carboxylic acid composite materials
|
|
US5773019A
(en)
*
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US5888493A
(en)
*
|
1996-12-05 |
1999-03-30 |
Sawaya; Assad S. |
Ophthalmic aqueous gel formulation and related methods
|
|
DE19718826A1
(de)
*
|
1997-05-05 |
1998-11-12 |
Marion S Dr Eckmiller |
Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
|
|
ES2232005T3
(es)
*
|
1997-08-11 |
2005-05-16 |
Allergan, Inc. |
Dispositivo de implante biodegradable esteril que contiene retinoide con biocompatibilidad mejorada y metodo de preparacion.
|
|
US6309374B1
(en)
|
1998-08-03 |
2001-10-30 |
Insite Vision Incorporated |
Injection apparatus and method of using same
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
US6113638A
(en)
*
|
1999-02-26 |
2000-09-05 |
Williams; Lytton A. |
Method and apparatus for intervertebral implant anchorage
|
|
ES2328570T3
(es)
|
1999-04-26 |
2009-11-16 |
Glaukos Corporation |
Dispositivo de derivacion y metodo para tratar el glaucoma.
|
|
DE19947711B4
(de)
*
|
1999-10-04 |
2004-02-12 |
Schrage, Norbert, Priv. Doz. Dr.med. |
Implantat zum Eisatz in der Glaukomtherapie
|
|
DE60040876D1
(de)
|
1999-10-21 |
2009-01-02 |
Alcon Inc |
Medikamentenzuführeinrichtung
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
WO2001028473A1
(en)
|
1999-10-21 |
2001-04-26 |
Alcon Universal Ltd. |
Sub-tenon drug delivery
|
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6852688B2
(en)
|
2000-03-10 |
2005-02-08 |
University Of Florida |
Compositions for treating diabetic retinopathy and methods of using same
|
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
|
US6692759B1
(en)
*
|
2000-06-28 |
2004-02-17 |
The Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
EP3167872B1
(de)
|
2000-07-05 |
2020-10-14 |
Allergan, Inc. |
Verfahren zur behandlung von entzündungsbedingten zuständen der augen
|
|
CA2420038C
(en)
|
2000-08-30 |
2010-11-09 |
John Hopkins University |
Devices for intraocular drug delivery
|
|
JP3780333B2
(ja)
*
|
2000-09-22 |
2006-05-31 |
国立大学法人大阪大学 |
外来性遺伝物質又は生理活性物質を細胞内へ導入する新規な方法
|
|
WO2002058730A2
(en)
*
|
2000-11-01 |
2002-08-01 |
Allergan, Inc. |
Compositions for treatment of ocular neovascularization
|
|
US20030082183A1
(en)
*
|
2000-11-01 |
2003-05-01 |
Wheeler Larry A. |
Methods and compositions for treatment of ocular neovascularization and neural injury
|
|
EP1621219A3
(de)
*
|
2000-11-29 |
2006-03-22 |
Allergan, Inc. |
Intraokulare Implantate zur Verhinderung von Transplantatabstossung im Auge
|
|
AU3649502A
(en)
*
|
2000-11-29 |
2002-06-11 |
Oculex Pharm Inc |
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
|
EP2263621B1
(de)
|
2001-04-07 |
2015-05-20 |
Glaukos Corporation |
System zum Testen von Augenstörungen
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
|
AU2002305400A1
(en)
|
2001-05-03 |
2002-11-18 |
Glaukos Corporation |
Medical device and methods of use for glaucoma treatment
|
|
JP2004536631A
(ja)
|
2001-05-03 |
2004-12-09 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
移植可能な薬物送達デバイスおよびその使用
|
|
ATE506929T1
(de)
|
2001-06-12 |
2011-05-15 |
Univ Johns Hopkins Med |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
|
US7592016B2
(en)
*
|
2001-06-28 |
2009-09-22 |
Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
PL204644B1
(pl)
|
2001-07-23 |
2010-01-29 |
Alcon |
Okulistyczne urządzenie do podawania leków
|
|
DE60214697T2
(de)
*
|
2001-07-23 |
2007-09-13 |
Alcon Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
US6482428B1
(en)
*
|
2001-08-13 |
2002-11-19 |
Philip S Li |
Weighted eyelid implant
|
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
|
AU2003218127B2
(en)
*
|
2002-03-11 |
2007-07-12 |
Alcon, Inc. |
Implantable drug delivery system
|
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
|
ES2295647T3
(es)
*
|
2002-07-15 |
2008-04-16 |
Alcon, Inc. |
Composiciones de implante farmaceuticas lipofilas, no polimeras, para uso intraocular.
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
|
WO2004026347A2
(en)
*
|
2002-09-17 |
2004-04-01 |
Iscience Surgical Corporation |
Apparatus and method for surgical bypass of aqueous humor
|
|
BRPI0314288B8
(pt)
|
2002-09-18 |
2021-06-22 |
Allergan Inc |
aparelhos para o envio de implantes oculares
|
|
US6899717B2
(en)
*
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
US7468065B2
(en)
|
2002-09-18 |
2008-12-23 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
US20040137059A1
(en)
|
2003-01-09 |
2004-07-15 |
Thierry Nivaggioli |
Biodegradable ocular implant
|
|
US20060154910A1
(en)
*
|
2003-02-20 |
2006-07-13 |
Bingaman David P |
Use of steroids to treat ocular disorders
|
|
CA2516790A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Alcon, Inc. |
Formulations of glucocorticoids to treat pathologic ocular angiogenesis
|
|
ATE476960T1
(de)
|
2003-05-02 |
2010-08-15 |
Surmodics Inc |
System zur kontrollierten freisetzung eines bioaktiven wirkstoffs im hinteren bereich des auges
|
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
|
US7589107B2
(en)
*
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US20040259765A1
(en)
*
|
2003-06-13 |
2004-12-23 |
Bingaman David P. |
Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
|
|
JP2007526019A
(ja)
*
|
2003-07-10 |
2007-09-13 |
アルコン，インコーポレイティド |
眼科用薬物送達デバイス
|
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
|
CN1882338A
(zh)
|
2003-09-18 |
2006-12-20 |
马库赛特公司 |
经巩膜递送
|
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
US20050130906A1
(en)
*
|
2003-11-20 |
2005-06-16 |
Matier William L. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
CN1946417A
(zh)
|
2003-12-05 |
2007-04-11 |
阿德内克休斯治疗公司 |
2型血管内皮生长因子受体的抑制剂
|
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
|
BRPI0506983A
(pt)
|
2004-01-20 |
2007-07-03 |
Allergan Inc |
composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
|
|
US7691381B2
(en)
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
|
WO2005107708A1
(en)
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase inhibitors implants
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US20050244472A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
AU2011213904B2
(en)
*
|
2004-04-30 |
2014-06-05 |
Allergan, Inc. |
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
|
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US9498457B2
(en)
*
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US8591885B2
(en)
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
US20070212395A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Allergan, Inc. |
Ocular therapy using sirtuin-activating agents
|
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US7108718B1
(en)
|
2004-07-12 |
2006-09-19 |
Philip Shihua Li |
Gold eyelid weight implant
|
|
US8246569B1
(en)
|
2004-08-17 |
2012-08-21 |
California Institute Of Technology |
Implantable intraocular pressure drain
|
|
EP1802373B1
(de)
*
|
2004-09-24 |
2011-07-06 |
RFE Pharma LLC |
Carboxy-amido-triazole zur lokalisierten behandlung von augenerkrankungen
|
|
US20160106717A1
(en)
|
2004-09-24 |
2016-04-21 |
Gen Pharma Holdings LLC |
Cai-based systems and methods for the localized treatment of uveitis
|
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US20060073172A1
(en)
*
|
2004-10-01 |
2006-04-06 |
Schneider L W |
Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
EP1793803B1
(de)
|
2004-10-01 |
2012-11-07 |
Ramscor, Inc. |
Einfach implantierbare wirkstoffzusammensetzungen mit verzögerter freisetzung
|
|
KR20070101865A
(ko)
*
|
2004-12-22 |
2007-10-17 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
|
WO2006086744A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
WO2006094014A2
(en)
|
2005-02-28 |
2006-09-08 |
The Regents Of The University Of California |
Methods for diagnosis and treatment of endometrial cancer
|
|
US20060204548A1
(en)
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
|
US20060233858A1
(en)
*
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
|
US8318906B2
(en)
|
2005-04-15 |
2012-11-27 |
The Regents Of The University Of California |
EMP2 antibodies and their therapeutic uses
|
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
US20060258994A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
|
CN101267779A
(zh)
|
2005-07-27 |
2008-09-17 |
福罗里达大学研究基金会有限公司 |
使用热休克治疗眼睛疾病
|
|
WO2007047626A1
(en)
*
|
2005-10-14 |
2007-04-26 |
Alcon, Inc. |
Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis
|
|
BRPI0613401B8
(pt)
|
2005-10-18 |
2021-05-25 |
Allergan Inc |
composição oftálmica compreendendo derivados de glicocorticoides que penetram seletivamente nos tecidos do segmento posterior
|
|
WO2007064752A2
(en)
|
2005-11-29 |
2007-06-07 |
Smithkline Beecham Corporation |
Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
WO2008029276A2
(en)
|
2006-02-02 |
2008-03-13 |
Allergan, Inc. |
Compositions and methods for the treatment of ophthalmic disease
|
|
JP5528708B2
(ja)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
安定な製剤ならびにそれらを調製および使用する方法
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
US20070202186A1
(en)
|
2006-02-22 |
2007-08-30 |
Iscience Interventional Corporation |
Apparatus and formulations for suprachoroidal drug delivery
|
|
EP2319558B1
(de)
*
|
2006-03-14 |
2014-05-21 |
University Of Southern California |
Mems-Vorrichtung zur Wirkstofffreisetzung
|
|
ES2563288T3
(es)
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
|
MX2008012601A
(es)
|
2006-03-31 |
2009-02-10 |
Qlt Plug Delivery Inc |
Metodos de suministro de farmaco, estructuras, y composiciones para un sistema nasolagrimal.
|
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US9039761B2
(en)
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
|
EP2052698A4
(de)
*
|
2006-08-08 |
2010-01-06 |
Fundacion Inasmet |
Implantierbares optisches system, entwicklungsverfahren dafür und anwendungen
|
|
US8039010B2
(en)
*
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
US8586556B2
(en)
*
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
|
AU2007319383A1
(en)
|
2006-11-10 |
2008-05-22 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
|
JP5537946B2
(ja)
|
2006-11-22 |
2014-07-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｉｇｆ−ｉｒを含むチロシンキナーゼ受容体に対する改変タンパク質に基づく標的治療薬
|
|
CA2670990A1
(en)
|
2006-12-01 |
2008-06-12 |
Allergan, Inc. |
Method for determining optimum intraocular locations for drug delivery systems
|
|
US8969415B2
(en)
*
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
US8846073B2
(en)
*
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
|
US8231892B2
(en)
*
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
|
BRPI0820176B8
(pt)
|
2007-11-08 |
2021-06-22 |
Alimera Sciences Inc |
dispositivo de implantação ocular e kit para liberar um implante
|
|
JP5542691B2
(ja)
|
2007-12-20 |
2014-07-09 |
ユニバーシティ オブ サザン カリフォルニア |
治療薬を送達するための装置および方法
|
|
PL2240220T3
(pl)
*
|
2008-01-03 |
2016-09-30 |
|
Wszczepialne urządzenia do podawania leków i aparaty do napełniania urządzeń
|
|
KR20100128291A
(ko)
|
2008-02-14 |
2010-12-07 |
브리스톨-마이어스 스큅 컴퍼니 |
Ｅｇｆｒ에 결합하는 조작된 단백질을 기초로 하는 표적화된 치료제
|
|
EP2323716B1
(de)
*
|
2008-05-08 |
2015-03-04 |
MiniPumps, LLC |
Arzneiabgabepumpen
|
|
US9623174B2
(en)
*
|
2008-05-08 |
2017-04-18 |
Minipumps, Llc |
Implantable pumps and cannulas therefor
|
|
CN102202706A
(zh)
*
|
2008-05-08 |
2011-09-28 |
迷你泵有限责任公司 |
可植入药物传送装置与用于填充该装置的设备和方法
|
|
US9849238B2
(en)
|
2008-05-08 |
2017-12-26 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
|
AR071874A1
(es)
|
2008-05-22 |
2010-07-21 |
Bristol Myers Squibb Co |
Proteinas de dominio de armazon basadas en fibronectina multivalentes
|
|
US8821870B2
(en)
|
2008-07-18 |
2014-09-02 |
Allergan, Inc. |
Method for treating atrophic age related macular degeneration
|
|
HUE061548T2
(hu)
|
2008-11-10 |
2023-07-28 |
Alexion Pharma Inc |
Komplementtel összefüggõ rendellenességek kezelésére szolgáló eljárások és készítmények
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
US8034813B2
(en)
|
2008-11-18 |
2011-10-11 |
Bausch & Lomb Incorporated |
Polymorphs of brimonidine pamoate
|
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
|
|
US8545554B2
(en)
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
|
US8425473B2
(en)
|
2009-01-23 |
2013-04-23 |
Iscience Interventional Corporation |
Subretinal access device
|
|
CN104887389B
(zh)
|
2009-01-29 |
2017-06-23 |
弗赛特影像4股份有限公司 |
后段给药
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
RU2559526C2
(ru)
|
2009-02-24 |
2015-08-10 |
Алексион Фармасьютикалз, Инк. |
Антитела, содержащие терапевтические пептиды-миметики тро/еро
|
|
JP5342301B2
(ja)
*
|
2009-03-30 |
2013-11-13 |
三菱重工業株式会社 |
太陽光集光受熱器
|
|
US8632511B2
(en)
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP4289416A3
(de)
|
2009-05-18 |
2024-01-03 |
Dose Medical Corporation |
Arzneimittel freisetzendes augenimplantat
|
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8987241B2
(en)
|
2009-06-19 |
2015-03-24 |
Altos Vision Limited |
Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
|
|
BRPI1012759A2
(pt)
|
2009-06-23 |
2019-07-02 |
Alexion Pharma Inc |
anticorpos biespecíficos que se ligam as proteínas do complemento.
|
|
EP2467797B1
(de)
|
2009-08-18 |
2017-07-19 |
MiniPumps, LLC |
Elektrolytische arzneimittelverabreichungspumpe mit adaptiver steuerung
|
|
WO2011039648A1
(en)
|
2009-09-30 |
2011-04-07 |
Glaxo Wellcome Manufacturing Pte Ltd. |
Methods of administration and treatment
|
|
WO2011053841A1
(en)
*
|
2009-10-30 |
2011-05-05 |
Aton Pharma, Inc. |
Ocular drug delivery devices
|
|
US20110124736A1
(en)
|
2009-11-09 |
2011-05-26 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
|
JP5911805B2
(ja)
|
2009-11-20 |
2016-04-27 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
上皮膜タンパク質−２（ｅｍｐ２）および増殖性硝子体網膜症（ｐｖｒ）
|
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
|
EP2525776B1
(de)
|
2010-01-22 |
2015-10-28 |
Allergan, Inc. |
Intrakamerale implantate mit retard-therapeutika
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
AU2011217785B2
(en)
|
2010-02-19 |
2015-06-18 |
The Regents Of The University Of California |
Epithelial membrane protein 2 (EMP2) binding reagents and their therapeutic uses in ocular diseases
|
|
AU2011245117B2
(en)
|
2010-04-30 |
2015-03-12 |
Alexion Pharmaceuticals, Inc. |
Anti-C5a antibodies and methods for using the antibodies
|
|
WO2011150133A2
(en)
|
2010-05-26 |
2011-12-01 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins having improved stability
|
|
AU2011270959A1
(en)
|
2010-06-22 |
2013-01-10 |
Musc Foundation For Research Development |
Antibodies to the C3d fragment of complement component 3
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
ES2888906T3
(es)
|
2010-08-05 |
2022-01-10 |
Forsight Vision4 Inc |
Aparato inyector para la administración de fármacos
|
|
US9492315B2
(en)
|
2010-08-05 |
2016-11-15 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
CN106214321B
(zh)
|
2010-10-15 |
2018-08-28 |
科尼尔赛德生物医学公司 |
用于进入眼睛的装置
|
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
JP6150734B2
(ja)
|
2011-02-03 |
2017-06-21 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
同種移植片の生存を長期化するための抗ｃｄ２００抗体の使用
|
|
US10286146B2
(en)
|
2011-03-14 |
2019-05-14 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US9603997B2
(en)
|
2011-03-14 |
2017-03-28 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
EP4249059B1
(de)
|
2011-06-28 |
2025-07-30 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
|
EP3659495B1
(de)
|
2011-09-13 |
2022-12-14 |
Dose Medical Corporation |
Intraokularer physiologischer sensor
|
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
|
SG11201400815TA
(en)
|
2011-10-12 |
2014-09-26 |
Ascendis Pharma Ophthalmology Division As |
Prevention and treatment of ocular conditions
|
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
US9308355B2
(en)
|
2012-06-01 |
2016-04-12 |
Surmodies, Inc. |
Apparatus and methods for coating medical devices
|
|
US10413620B2
(en)
|
2012-08-17 |
2019-09-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
|
|
JP2015535212A
(ja)
|
2012-08-17 |
2015-12-10 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト |
補体活性化を検出するための組成物および方法
|
|
US11090468B2
(en)
|
2012-10-25 |
2021-08-17 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
ES3023054T3
(en)
|
2012-11-08 |
2025-05-29 |
Clearside Biomedical Inc |
Methods for the treatment of ocular disease in human subjects
|
|
JP6100008B2
(ja)
*
|
2013-02-06 |
2017-03-22 |
正敏 村田 |
生体用インプラント
|
|
CA2901280A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
|
WO2014164703A1
(en)
|
2013-03-11 |
2014-10-09 |
University Of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
EP2968113B8
(de)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systeme zur verzögerten intraokularen abgabe schwerlöslicher verbindungen aus einem implantat mit einem portabgabesystem
|
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
EP2978393B1
(de)
|
2013-03-28 |
2023-12-27 |
ForSight Vision4, Inc. |
Augenimplantat zur abgabe von therapeutischen substanzen
|
|
WO2014160958A1
(en)
|
2013-03-29 |
2014-10-02 |
Alexion Pharmaceuticals, Inc. |
Compositions and methods for increasing the serum half-life of a therapeutic agent targeting complement c5
|
|
MX372859B
(es)
|
2013-05-03 |
2020-07-07 |
Clearside Biomedical Inc |
Aparatos y métodos para inyección ocular.
|
|
KR102192596B1
(ko)
|
2013-08-07 |
2020-12-18 |
알렉시온 파마슈티칼스, 인코포레이티드 |
비정형적 용혈성 요독증후군 (ahus) 바이오마커 단백질
|
|
HUE036554T2
(hu)
|
2013-10-31 |
2018-07-30 |
Allergan Inc |
Prosztamidtartalmú intraokuláris implantátumok és felhasználásuk módszerei
|
|
ES2864274T3
(es)
|
2013-11-14 |
2021-10-13 |
Eyed Pharma |
Dispositivo ocular
|
|
US10010447B2
(en)
|
2013-12-18 |
2018-07-03 |
Novartis Ag |
Systems and methods for subretinal delivery of therapeutic agents
|
|
NZ631007A
(en)
|
2014-03-07 |
2015-10-30 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
|
EP3148491B1
(de)
|
2014-05-29 |
2020-07-01 |
Glaukos Corporation |
Implantate mit kontrollierter arzneimittelfreisetzung und herstellungsverfahren davon
|
|
KR102416726B1
(ko)
|
2014-07-15 |
2022-07-05 |
포사이트 비젼4, 인크. |
안구 이식물 전달 디바이스 및 방법
|
|
US9474756B2
(en)
|
2014-08-08 |
2016-10-25 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
SG11201702304UA
(en)
|
2014-10-03 |
2017-04-27 |
Ntercept Llc |
Compositions and methods for inhibiting the biological activity of soluble biomolecules
|
|
US10500091B2
(en)
|
2014-11-10 |
2019-12-10 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
|
TWM508597U
(zh)
|
2014-12-05 |
2015-09-11 |
Zhong He Ya Co Ltd |
液體加壓幫浦出力軸潤滑結構
|
|
WO2016123454A1
(en)
|
2015-01-29 |
2016-08-04 |
Board Of Trustees Of Miching State University |
Cryptic polypeptides and uses thereof
|
|
WO2016145389A1
(en)
|
2015-03-12 |
2016-09-15 |
Board Of Trustees Of Michigan State University |
Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases
|
|
WO2016183183A1
(en)
|
2015-05-11 |
2016-11-17 |
The Johns Hopkins University |
Autoimmune antibodies for use in inhibiting cancer cell growth
|
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
CA3005238A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
EP3413851B1
(de)
|
2016-02-10 |
2023-09-27 |
Clearside Biomedical, Inc. |
Verpackung
|
|
US10883108B2
(en)
|
2016-03-31 |
2021-01-05 |
The Schepens Eye Research Institute, Inc. |
Endomucin inhibitor as an anti-angiogenic agent
|
|
US11617680B2
(en)
|
2016-04-05 |
2023-04-04 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
WO2017176762A1
(en)
|
2016-04-06 |
2017-10-12 |
Nanotics, Llc |
Particles comprising subparticles or nucleic acid scaffolds
|
|
EP3442479B1
(de)
|
2016-04-20 |
2026-03-04 |
Glaukos Corporation |
Vorrichtung zur verabreichung eines bioresorbierbaren okularen medikaments
|
|
CA3062845A1
(en)
|
2016-05-02 |
2017-11-09 |
Clearside Biomedical, Inc. |
Systems and methods for ocular drug delivery
|
|
BR112018073945A2
(pt)
|
2016-05-27 |
2019-02-26 |
Alexion Pharmaceuticals, Inc. |
métodos para tratamento de miastenia grave generalizada refratária
|
|
US10463532B2
(en)
|
2016-07-26 |
2019-11-05 |
Masatoshi Murata |
Method for placing implant in choroid that can less invasively and simply place implant in choroid in optic disc-macula area
|
|
CN110177527B
(zh)
|
2016-08-12 |
2022-02-01 |
科尼尔赛德生物医学公司 |
用于调节药剂递送用针的插入深度的装置和方法
|
|
EP3541408B1
(de)
|
2016-11-15 |
2024-11-13 |
The Schepens Eye Research Institute, Inc. |
Zusammensetzungen und verfahren zur behandlung von aberrierender angiogene
|
|
US12090294B2
(en)
|
2017-05-02 |
2024-09-17 |
Georgia Tech Research Corporation |
Targeted drug delivery methods using a microneedle
|
|
US20190062428A1
(en)
|
2017-06-19 |
2019-02-28 |
Surface Oncology, Inc. |
Combination of anti-cd47 antibodies and cell death-inducing agents, and uses thereof
|
|
SG11201913137VA
(en)
|
2017-07-11 |
2020-01-30 |
Compass Therapeutics Llc |
Agonist antibodies that bind human cd137 and uses thereof
|
|
SI3658184T1
(sl)
|
2017-07-27 |
2024-01-31 |
Alexion Pharmaceuticals, Inc., |
Formulacije z visoko koncentracijo protiteles proti-C5
|
|
EP4234025A3
(de)
|
2017-08-11 |
2024-04-24 |
Unity Biotechnology, Inc. |
Behandlung von diabetischer retinopathie mit pharmazeutischen wirkstoffen zur eliminierung seneszenter zellen
|
|
US11485781B2
(en)
|
2017-08-17 |
2022-11-01 |
Massachusetts Institute Of Technology |
Multiple specificity binders of CXC chemokines
|
|
KR20200051706A
(ko)
|
2017-09-08 |
2020-05-13 |
브리스톨-마이어스 스큅 컴퍼니 |
비알콜성 지방간염 (nash)을 치료하는 방법에 사용하기 위한 변형된 섬유모세포 성장 인자 21 (fgf-21)
|
|
US11761963B2
(en)
|
2017-09-27 |
2023-09-19 |
Alexion Pharmaceuticals, Inc. |
Biomarker signature for predicting tumor response to anti-CD200 therapy
|
|
WO2019070917A1
(en)
|
2017-10-03 |
2019-04-11 |
The Schepens Eye Research Institute, Inc. |
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME
|
|
WO2019084438A1
(en)
|
2017-10-26 |
2019-05-02 |
Alexion Pharmaceuticals, Inc. |
ASSAY AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR THE TREATMENT OF NOCTURNAL PAROXYSTIC HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC AND UREMIC SYNDROME (AHUS)
|
|
US11718679B2
(en)
|
2017-10-31 |
2023-08-08 |
Compass Therapeutics Llc |
CD137 antibodies and PD-1 antagonists and uses thereof
|
|
WO2019099560A1
(en)
|
2017-11-14 |
2019-05-23 |
The Schepens Eye Research Institute, Inc. |
Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
|
US11851497B2
(en)
|
2017-11-20 |
2023-12-26 |
Compass Therapeutics Llc |
CD137 antibodies and tumor antigen-targeting antibodies and uses thereof
|
|
JP7314155B2
(ja)
|
2017-11-21 |
2023-07-25 |
フォーサイト・ビジョン４・インコーポレーテッド |
膨張可能ポート送達システムのための流体交換装置及びその使用方法
|
|
BR122022000386B1
(pt)
|
2018-03-14 |
2022-09-27 |
Surface Oncology, Inc |
Anticorpos que se ligam a cd39, composição farmacêutica e kit dos mesmos
|
|
CN120173101A
(zh)
|
2018-03-22 |
2025-06-20 |
表面肿瘤学有限责任公司 |
抗il-27抗体及其用途
|
|
WO2019200357A1
(en)
|
2018-04-12 |
2019-10-17 |
Surface Oncology, Inc. |
Biomarker for cd47 targeting therapeutics and uses therefor
|
|
CN112105733B
(zh)
|
2018-04-19 |
2024-10-29 |
查美特制药公司 |
合成rig-i样受体激动剂
|
|
CA3099308A1
(en)
|
2018-05-21 |
2019-11-28 |
Compass Therapeutics Llc |
Compositions and methods for enhancing the killing of target cells by nk cells
|
|
WO2019226658A1
(en)
|
2018-05-21 |
2019-11-28 |
Compass Therapeutics Llc |
Multispecific antigen-binding compositions and methods of use
|
|
WO2019231983A1
(en)
|
2018-05-31 |
2019-12-05 |
Alexion Pharmaceuticals, Inc. |
Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) in pediatric patients
|
|
EP3802603A1
(de)
|
2018-06-04 |
2021-04-14 |
Alexion Pharmaceuticals, Inc. |
Dosierung und verabreichung von anti-c5-antikörpern zur behandlung des atypischen hämolytisch-urämischen syndroms (ahus) bei kindern
|
|
US12312394B2
(en)
|
2018-06-28 |
2025-05-27 |
Alexion Pharmaceuticals, Inc. |
Methods of producing anti-C5 antibodies
|
|
US20220275043A1
(en)
|
2018-07-17 |
2022-09-01 |
Massachusetts Institute Of Technology |
Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
|
|
WO2020033925A2
(en)
|
2018-08-09 |
2020-02-13 |
Compass Therapeutics Llc |
Antibodies that bind cd277 and uses thereof
|
|
EP3833442A2
(de)
|
2018-08-09 |
2021-06-16 |
Compass Therapeutics LLC |
Antikörper zur bindung von cd277 und verwendungen davon
|
|
WO2020033923A1
(en)
|
2018-08-09 |
2020-02-13 |
Compass Therapeutics Llc |
Antigen binding agents that bind cd277 and uses thereof
|
|
JP2022512632A
(ja)
|
2018-10-30 |
2022-02-07 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
発作性夜間ヘモグロビン尿症（ｐｎｈ）の処置のための抗ｃ５抗体の皮下投薬及び投与
|
|
EP3876924A4
(de)
|
2018-11-06 |
2022-08-10 |
Georgetown University |
Behandlung von nichtalkoholischer steatohepatitis mit cck-inhibitoren
|
|
BR112021008795A2
(pt)
|
2018-11-13 |
2021-08-31 |
Compass Therapeutics Llc |
Construtos de ligação multiespecíficos contra moléculas de ponto de verificação e seus usos
|
|
US11628466B2
(en)
|
2018-11-29 |
2023-04-18 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
BR112021011393A2
(pt)
|
2018-12-13 |
2021-08-31 |
Surface Oncology, Inc. |
Anticorpos anti-il-27 e usos dos mesmos
|
|
CA3127072A1
(en)
|
2019-01-16 |
2020-07-23 |
Compass Therapeutics Llc |
Formulations of antibodies that bind human cd137 and uses thereof
|
|
EP3920899A2
(de)
|
2019-02-08 |
2021-12-15 |
The UAB Research Foundation |
Immuntherapie zur behandlung und vorbeugung von entzündlichen darmerkrankungen
|
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
EP4031178A1
(de)
|
2019-09-16 |
2022-07-27 |
Surface Oncology, Inc. |
Anti-cd39-antikörperzusammensetzungen und verfahren
|
|
CN115087671A
(zh)
|
2019-09-25 |
2022-09-20 |
表面肿瘤学公司 |
抗il-27抗体及其用途
|
|
WO2021067526A1
(en)
|
2019-10-02 |
2021-04-08 |
Alexion Pharmaceuticals, Inc. |
Complement inhibitors for treating drug-induced complement-mediated response
|
|
WO2021081353A1
(en)
|
2019-10-23 |
2021-04-29 |
Checkmate Pharmaceuticals, Inc. |
Synthetic rig-i-like receptor agonists
|
|
US11459389B2
(en)
|
2019-10-24 |
2022-10-04 |
Massachusetts Institute Of Technology |
Monoclonal antibodies that bind human CD161
|
|
US12084509B2
(en)
|
2020-04-30 |
2024-09-10 |
Duke University |
Gene signatures for monitoring acute rejection and methods of using same
|
|
CN115667925A
(zh)
|
2020-05-15 |
2023-01-31 |
阿雷克森制药公司 |
使用细胞外囊泡来检测补体激活的方法以及其用于评估和/或监测补体介导的疾病的治疗的用途
|
|
CN115811995B
(zh)
|
2020-05-15 |
2023-11-03 |
视觉流公司 |
用于在哺乳动物眼睛的常规房水流出通路中植入的方法和设备
|
|
US12577621B2
(en)
|
2020-09-08 |
2026-03-17 |
Duke University |
LRRK2 mutations as biomarkers for the prediction of immune checkpoint response in cancer
|
|
US12496612B2
(en)
|
2021-01-08 |
2025-12-16 |
Surmodics, Inc. |
Coating application system and methods for coating rotatable medical devices
|
|
JP2024516970A
(ja)
|
2021-05-07 |
2024-04-18 |
サーフィス オンコロジー， エルエルシー |
抗ｉｌ－２７抗体及びその使用
|
|
US20250199013A1
(en)
|
2021-05-28 |
2025-06-19 |
Alexion Pharmaceuticals, Inc. |
Methods for detecting cm-tma biomarkers
|
|
KR20240026984A
(ko)
|
2021-07-07 |
2024-02-29 |
제넨테크, 인크. |
로드 삽입기 시스템 및 방법
|
|
US20250049758A1
(en)
|
2021-12-06 |
2025-02-13 |
Breye Therapeutics Aps |
Danegaptide Formulation for Application in the Eye
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
WO2023230116A1
(en)
|
2022-05-25 |
2023-11-30 |
Surface Oncology, Inc. |
Use of anti-il-27 antibodies
|
|
WO2023230128A1
(en)
|
2022-05-25 |
2023-11-30 |
Surface Oncology, Inc. |
Use of anti-il-27 antibodies
|
|
JP2025529318A
(ja)
|
2022-09-06 |
2025-09-04 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
造血幹細胞移植関連血栓性微小血管症（ｈｓｃｔ－ｔｍａ）を有する患者における診断及び予後バイオマーカプロファイル
|
|
WO2024238421A1
(en)
|
2023-05-12 |
2024-11-21 |
Alexion Pharmaceuticals, Inc. |
Use of biomarkers for the identification and treatment of complement-mediated disorders
|
|
WO2024238422A1
(en)
|
2023-05-12 |
2024-11-21 |
Alexion Pharmaceuticals, Inc. |
Use of a panel of lectins for detection of complement biomarkers in urine extracellular vesicles
|
|
WO2026055167A1
(en)
|
2024-09-05 |
2026-03-12 |
Surface Oncology, LLC |
Anti-il-27 antibodies and use of biomarkers in uses thereof
|
|
WO2026055168A1
(en)
|
2024-09-06 |
2026-03-12 |
Surface Oncology, LLC |
Anti-il-27 antibodies and uses and doses thereof
|